Huaxi Biology (688363.SH): Fermented sodium chondroitin sulfate completes the registration of the main documents of medical devices.

Zhimedia Finance APP news, Huaxi Bio (688363.SH) announced that the company's independently developed fermentation-based chondroitin sulfate sodium raw material (referred to as "chondroitin sulfate sodium") has successfully passed the main document filing registration of the Medical Device Technical Evaluation Center (CMDE) of the National Medical Products Administration, with the registration number M2025264-000, becoming the first enterprise in China to achieve compliance filing for fermentation-based chondroitin sulfate sodium.